Literature DB >> 10886126

A drug interaction between fusidic acid and a combination of ritonavir and saquinavir.

Y Khaliq, K Gallicano, R Leger, B Foster, A Badley.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10886126      PMCID： PMC2014974          DOI： 10.1046/j.1365-2125.2000.00207-2.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  6 in total

1.  Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection.

Authors:  M S Sulkowski; D L Thomas; R E Chaisson; R D Moore
Journal:  JAMA       Date:  2000-01-05       Impact factor: 56.272

Review 2.  The pharmacokinetics of fusidic acid.

Authors:  D S Reeves
Journal:  J Antimicrob Chemother       Date:  1987-10       Impact factor: 5.790

3.  Ritonavir and saquinavir combination therapy for the treatment of HIV infection.

Authors:  D W Cameron; A J Japour; Y Xu; A Hsu; J Mellors; C Farthing; C Cohen; D Poretz; M Markowitz; S Follansbee; J B Angel; D McMahon; D Ho; V Devanarayan; R Rode; M Salgo; D J Kempf; R Granneman; J M Leonard; E Sun
Journal:  AIDS       Date:  1999-02-04       Impact factor: 4.177

4.  A short-term study of the safety, pharmacokinetics, and efficacy of ritonavir, an inhibitor of HIV-1 protease. European-Australian Collaborative Ritonavir Study Group.

Authors:  S A Danner; A Carr; J M Leonard; L M Lehman; F Gudiol; J Gonzales; A Raventos; R Rubio; E Bouza; V Pintado
Journal:  N Engl J Med       Date:  1995-12-07       Impact factor: 91.245

5.  Pharmacokinetics of intravenous fusidic acid in patients with cholestasis.

Authors:  J D Peter; F Jehl; T Pottecher; J P Dupeyron; H Monteil
Journal:  Antimicrob Agents Chemother       Date:  1993-03       Impact factor: 5.191

Review 6.  Ritonavir. Clinical pharmacokinetics and interactions with other anti-HIV agents.

Authors:  A Hsu; G R Granneman; R J Bertz
Journal:  Clin Pharmacokinet       Date:  1998-10       Impact factor: 6.447
  6 in total
  4 in total

Review 1.  Drug interactions between antiretroviral drugs and comedicated agents.

Authors:  Monique M R de Maat; G Corine Ekhart; Alwin D R Huitema; Cornelis H W Koks; Jan W Mulder; Jos H Beijnen
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

2.  Population pharmacokinetics of rifampicin in adult patients with osteoarticular infections: interaction with fusidic acid.

Authors:  Amélie Marsot; Amelie Ménard; Julien Dupouey; Cedric Muziotti; Romain Guilhaumou; Olivier Blin
Journal:  Br J Clin Pharmacol       Date:  2017-01-16       Impact factor: 4.335

3.  Fusidic Acid Inhibits Hepatic Transporters and Metabolic Enzymes: Potential Cause of Clinical Drug-Drug Interaction Observed with Statin Coadministration.

Authors:  Anshul Gupta; Jennifer J Harris; Jianrong Lin; James P Bulgarelli; Bruce K Birmingham; Scott W Grimm
Journal:  Antimicrob Agents Chemother       Date:  2016-09-23       Impact factor: 5.191

4.  Rhabdomyolysis Induced by Coadministration of Fusidic Acid and Atorvastatin: A Case Report and Comprehensive Review of the Literature.

Authors:  Dimitrios Patoulias; Theodoros Michailidis; Thomas Papatolios; Rafael Papadopoulos; Petros Keryttopoulos
Journal:  Case Rep Nephrol       Date:  2017-10-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.